Company profile: Quadrant Biosciences
1.1 - Company Overview
Company description
- Provider of epigenetic diagnostics focused on early detection of neurological disorders, offering: a virtual pediatric clinic for autism evaluations via telehealth; molecular diagnostics for COVID-19, autism and Parkinsonβs; autism assessment workflow software; and wastewater monitoring for SARS-CoV-2 and other pathogens.
Products and services
- Quadrant Laboratories: Engineers and commercializes clinical-grade molecular diagnostics addressing health concerns like COVID-19, autism, and Parkinson's disease
- As You Are: Operates a telehealth-based pediatric clinic conducting autism diagnostic evaluations for children through online appointments
- Autism Analytica: Architects modular software streamlining clinical workflows and applying evidence-based assessment standards for autism to support standardized evaluations
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to Quadrant Biosciences
Minerva Neurosciences
HQ: United States
Website
- Description: Provider of clinical-stage biopharmaceutical product candidates for central nervous system diseases, including roluperidone (MIN-101) for negative symptoms of schizophrenia targeting serotonin, sigma, and alpha-adrenergic receptors, and MIN-301, a recombinant neuregulin-1Ξ²1 in preclinical development for Parkinsonβs disease aimed at restoring brain tissue damage and improving motor function.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Minerva Neurosciences company profile β
Cerevance
HQ: United States
Website
- Description: Provider of therapeutics for CNS disorders, leveraging its NETSseq platform to identify novel targets. Pipeline includes CVN424, a first-in-class compound targeting a novel receptor with phase 2 efficacy in Parkinsonβs disease; CVN766, a selective orexin 1 antagonist for psychiatric conditions focused on avoiding somnolence; and CVN293, a KCNK13 inhibitor under investigation for ALS and Alzheimerβs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Cerevance company profile β
Avid Radiopharmaceuticals
HQ: United States
Website
- Description: Provider of molecular imaging agents to aid detection and monitoring of chronic human diseases. Products include FDA-approved PET imaging agents: Amyvid for detecting beta-amyloid plaques in the brain and Tauvid for detecting tau pathology in patients evaluated for Alzheimer's disease. Based in Philadelphia, PA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Avid Radiopharmaceuticals company profile β
Pleo Pharma
HQ: United States
Website
- Description: Provider of pharmaceutical therapeutics development focused on PP-01, an oral prescription medication developed to treat Cannabis Use Disorder and Cannabis Withdrawal Syndrome, which has successfully completed Phase 2 clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Pleo Pharma company profile β
Enspire DBS
HQ: United States
Website
- Description: Provider of deep brain stimulation (DBS) therapy combined with physical rehabilitation to improve arm motor function in stroke recovery patients, including a clinical trial evaluating DBS safety and effectiveness with therapy and a weekly rehabilitation program as part of the trial.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Enspire DBS company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for Quadrant Biosciences
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Quadrant Biosciences
2.2 - Growth funds investing in similar companies to Quadrant Biosciences
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for Quadrant Biosciences
4.2 - Public trading comparable groups for Quadrant Biosciences
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β